BiCNU supply shortage
Executive Summary
Bristol-Myers Squibb announced Oct. 24 its supply difficulties with BiCNU (carmustine injection) are now a shortage; earlier the drug maker reported that it had a supply outage of the palliative cancer product ("1The Pink Sheet" Oct. 10, 2005, In Brief). The shortage is due to batches produced by a third-party supplier that needed additional assessment. Bristol has begun distributing a limited amount of the product...